Literature DB >> 32705305

Fatal cerebral infarct in a child with COVID-19.

Shingo Kihira1, Peter F Morgenstern2, Hillary Raynes3, Thomas P Naidich4, Puneet Belani4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32705305      PMCID: PMC7376273          DOI: 10.1007/s00247-020-04779-x

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


× No keyword cloud information.
Dear Editors, Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes a cytokine storm through angiotensin-converting enzyme 2 (ACE2) receptor binding, leading to a hypercoagulable state [1, 2]. This has led to increased incidence of vascular thromboses in people with coronavirus disease 2019 (COVID-19) [3, 4]. It has been reported that children with SARS-CoV-2 infrequently have severe disease [5]. At our institution in New York City, we saw only four cases of children presenting with SARS-CoV-2 infection and demonstrating Kawasaki-like symptomatology between March 15 and April 30 of 2020. Here we write about an unusual case to raise awareness that a post-infectious syndrome associated with SARS-CoV-2 can be fatal in children. A 5-year-old boy with no significant medical history presented with 3 days of fever, cough and abdominal pain. He was diagnosed with prior COVID-19 infection through plasma antibody assay. D-dimer at presentation was elevated (12 μg/mL; normal range <0.50 μg/mL). He was transferred to our hospital in New York City and started on a heparin drip. He became hypotensive and was moved to the pediatric intensive care unit, where he was intubated and started on titrated epinephrine infusion. Chest radiograph demonstrated coarse bronchovascular prominence and mild cardiomegaly. An echocardiogram demonstrated an ejection fraction of 30% and no structural cardiac anomalies. Cardiogenic shock secondary to inflammatory cytokine storm was suspected because of recent COVID-19 infection. He underwent veno-arterial extracorporeal membrane oxygenation (ECMO) cannulation. Over the next 4 days his condition improved. Hours prior to decannulation, his right pupil became dilated and non-reactive to light. Emergent decannulation was performed and a head CT (Fig. 1) revealed a large acute right anterior and middle cerebral artery territory infarction and subarachnoid hemorrhage in the left hemisphere. Immediately following CT scan his left pupil became fixed and dilated. Sugammadex was administered for rapid reversal of his residual vecuronium paralysis. Neurologic exam demonstrated absent corneal, gag and pupillary responses and no movement to painful stimuli. After discussion with his family no surgical decompression was attempted because of his clinical condition. He was declared brain dead 3 days later.
Fig. 1

Axial non-contrast head CT in a 5-year-old boy with recent COVID-19 infection demonstrates massive right anterior and middle cerebral artery infarction (asterisk) and subarachnoid hemorrhage in the left hemisphere (arrows)

Axial non-contrast head CT in a 5-year-old boy with recent COVID-19 infection demonstrates massive right anterior and middle cerebral artery infarction (asterisk) and subarachnoid hemorrhage in the left hemisphere (arrows) This is an unfortunate case of a healthy 5-year-old boy with COVID-19 infection complicated by cardiogenic shock and hypercoagulable state. The combination of cardiogenic shock and hypercoagulable state presumably contributed to the massive cerebral infarction, with the contributing role of ECMO cannulation uncertain. It is our hope that this case informs caregivers and imagers of a potentially devastating neurologic manifestation of COVID-19.
  5 in total

1.  Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.

Authors:  Mauro Panigada; Nicola Bottino; Paola Tagliabue; Giacomo Grasselli; Cristina Novembrino; Veena Chantarangkul; Antonio Pesenti; Flora Peyvandi; Armando Tripodi
Journal:  J Thromb Haemost       Date:  2020-06-24       Impact factor: 5.824

2.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

3.  Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.

Authors:  Yan Zhang; Meng Xiao; Shulan Zhang; Peng Xia; Wei Cao; Wei Jiang; Huan Chen; Xin Ding; Hua Zhao; Hongmin Zhang; Chunyao Wang; Jing Zhao; Xuefeng Sun; Ran Tian; Wei Wu; Dong Wu; Jie Ma; Yu Chen; Dong Zhang; Jing Xie; Xiaowei Yan; Xiang Zhou; Zhengyin Liu; Jinglan Wang; Bin Du; Yan Qin; Peng Gao; Xuzhen Qin; Yingchun Xu; Wen Zhang; Taisheng Li; Fengchun Zhang; Yongqiang Zhao; Yongzhe Li; Shuyang Zhang
Journal:  N Engl J Med       Date:  2020-04-08       Impact factor: 91.245

4.  COVID-19 in children: the link in the transmission chain.

Authors:  Alyson A Kelvin; Scott Halperin
Journal:  Lancet Infect Dis       Date:  2020-03-25       Impact factor: 25.071

5.  COVID-19 and its implications for thrombosis and anticoagulation.

Authors:  Jean M Connors; Jerrold H Levy
Journal:  Blood       Date:  2020-06-04       Impact factor: 25.476

  5 in total
  4 in total

Review 1.  Spectrum of neuroimaging mimics in children with COVID-19 infection.

Authors:  Alex Mun-Ching Wong; Cheng Hong Toh
Journal:  Biomed J       Date:  2021-11-15       Impact factor: 7.892

Review 2.  Thromboembolic complications in children with COVID-19 and MIS-C: A narrative review.

Authors:  Sandra Trapani; Chiara Rubino; Donatella Lasagni; Francesco Pegoraro; Massimo Resti; Gabriele Simonini; Giuseppe Indolfi
Journal:  Front Pediatr       Date:  2022-08-11       Impact factor: 3.569

Review 3.  Contributing factors to pediatric COVID-19 and MIS-C during the initial waves: A systematic review of 92 case reports.

Authors:  Muzna Sarfraz; Azza Sarfraz; Zouina Sarfraz; Zainab Nadeem; Javeria Khalid; Shehreena Zabreen Butt; Sindhu Thevuthasan; Miguel Felix; Ivan Cherrez-Ojeda
Journal:  Ann Med Surg (Lond)       Date:  2022-07-31

4.  Malignant cerebral infarction associated with COVID-19 in a child.

Authors:  Maria Rosaria Scala; Pietro Spennato; Domenico Cicala; Veronica Piccolo; Antonio Varone; Giuseppe Cinalli
Journal:  Childs Nerv Syst       Date:  2021-06-26       Impact factor: 1.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.